ADTX vs ONCO

ADTX exhibits severe financial distress, reflected in a Piotroski F-Score of 1/9 (indicating weak financial health) and a lack of an Altman Z-Score, which raises significant bankruptcy risk. The company is unprofitable with a negative ROA of -61.70%, a gross margin of 0.00%, and a staggering -419,870.30% operating margin. Revenue has collapsed by 89.10% YoY, and the stock has declined 100% over the past five years. Despite a low price of $1.82, the valuation metrics are nonsensical (e.g., Price/Sales of 67.96, negative P/E), suggesting extreme overvaluation or data failure. The absence of any analyst coverage and negative insider activity further confirm a lack of institutional confidence.

ONCO exhibits critical financial distress, anchored by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is in a catastrophic price collapse, falling from a 52-week high of $74.38 to $0.76, representing a near-total loss of market value. With a current ratio of 0.66 and revenue plummeting by 57.40% YoY, the firm faces an immediate liquidity crisis and a failing business model. The combination of extreme operating losses (-422.06% margin) and a bearish technical trend suggests a high probability of insolvency.